Official SEC submissions
Biodexa Pharmaceuticals SEC Filings
Biodexa Pharmaceuticals (BDRX) SEC filings, periodic reports and insider submis…
Direct answer
Biodexa Pharmaceuticals's latest SEC filing is 6-K.
Get free Biodexa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Recent SEC filings
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
20-F
Periodic report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
20-F
Periodic report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
6-K
Current report
Filed:
Report date:
Verified data
- Recent filing categories
- 2
- Recent filings
- 40
- SEC CIK
- 0001643918
- Latest filing date
- July 29, 2026